Online edition of India's National Newspaper
Friday, Mar 17, 2006
Google

Business
News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Jobs | Obituary |

Business - Briefly Printer Friendly Page   Send this Article to a Friend

Aurobindo Pharma gets NDA from USFDA

HYDERABAD: Aurobindo Pharma on Thursday announced the receipt of the first New Drug Approval (NDA) from the USFDA for Lamivudine 150 mg/Zidovudine 300 mg, fixed dose tablets co-packed with Efavirenz 600 mg tablets. The NDA provided the drugs for treatment of HIV-1 infection and there is no previous version of the co-packaged product approved by USFDA. This is Aurobindo Pharma's eleventh approval for the anti-retroviral segment and helps retain its position as a strong player in the segment, says a company release.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | Publications | eBooks | Images | Home |

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu